Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of monthly intramuscular GA Depot in relapsing multiple sclerosis
MOH_2020-07-14_009141Phase 3Completed
- Sponsor
- Mapi Pharma
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of glatiramer acetate in multiple sclerosis (MS) (2 arms), sponsored by Mapi Pharma. Started Apr 2020; status: completed.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on MOH_2020-07-14_009141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-07-14_009141.